Research Summaries

Research Summary
Research Summary
07/02/2024
Researchers who are a part of the American Gastroenterological Association (AGA) developed a list of guidelines for the use of fecal microbiota-based therapies in patients with Clostridioides difficile...
07/02/2024
Research Summary
Research Summary
04/05/2024

Anthony Calabro, MA

Anthony Calabro, MA
An international task force of 35 pediatric experts developed and validated new criteria for sepsis and septic shock in children and adolescents based on a large international database and a systematic...
04/05/2024
FDA Alert
FDA Alert
06/01/2023

Jessica Ganga

Jessica Ganga
The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.
06/01/2023
Research Summary
Research Summary
02/24/2023
Researchers sought to determine whether adults hospitalized for sepsis are at an increased risk of death or rehospitalization for cardiovascular events.
02/24/2023
Disease Prevention
Disease Prevention
12/13/2022
Following three studies that examined its safety and efficacy, the FDA approves the first fecal microbiota product to prevent recurring Clostridioides difficle infection in patients.
12/13/2022
Medication
Medication
10/26/2022
A new drug combination was found to be more effective for treating UTIs and acute pyelonephritis compared to the current standard treatment approach.
10/26/2022
Lyme Disease
Lyme Disease
08/17/2022
In the United States, the prevalence of Lyme disease cases continues to grow in certain parts of the country causing an increased public health concern.
08/17/2022
Antibiotic Resistence
Antibiotic Resistence
12/02/2021
The Infectious Diseases Society of America has published treatment guidance on 3 of the most common drug-resistant pathogens: AmpC b-lactamase producing Enterobacterales, Carbapenem-resistant Acinetobacter...
12/02/2021
bacterial infections
bacterial infections
11/11/2021
To determine the in-vitro susceptibilities of delafloxacin and the comparator quinolones, the researchers tested clinical isolates from patients with community-acquired pneumonia and lower respiratory tract...
11/11/2021
Lung Infections
Lung Infections
10/20/2021
To investigate the efficacy and safety of lefamulin in patients with CABP who have or may be at risk for severe pneumonia, the researchers analyzed pooled data from the LEAP 1 and 2 trials based on whether...
10/20/2021